학술논문

Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
Document Type
Journal
Source
BLOOD; FEB 22 2024, 143 8, 8p.
Subject
Language
English
ISSN
15280020